{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:45:59Z","timestamp":1782708359544,"version":"3.54.5"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Significant advancements have been made in kidney transplantation, with a wealth of immunosuppressive and antimicrobial therapies that have significantly improved graft survival. Despite these accomplishments, the ability to promptly identify kidney allograft pathology for these therapies has been limited by the reliance on kidney biopsy as the gold-standard diagnostic modality, which is invasive. To overcome these limitations, non-invasive biomarkers have been developed over the past two decades. Donor-derived cell-free DNA, gene expression profiling, urinary chemokines, extracellular vesicles, microRNA, and Torque Teno Virus are candidates near or already in clinical use. This mini-review discusses the strengths and limitations of these biomarkers for the surveillance and prognostication of renal allografts.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1801117","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:26:13Z","timestamp":1782707173000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Promising non-invasive biomarkers for kidney allograft monitoring: a mini review"],"prefix":"10.3389","volume":"17","author":[{"given":"Luke","family":"Barr","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Nephrology and Hypertension, Northwestern University, Feinberg School of Medicine","place":["Chicago, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fareeha","family":"Mubin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Jefferson Einstein Philadelphia Hospital","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Friedewald","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology and Hypertension, Northwestern University, Feinberg School of Medicine","place":["Chicago, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook Hyeon","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology and Hypertension, Northwestern University, Feinberg School of Medicine","place":["Chicago, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16463","article-title":"Long-term kidney transplant graft survival-making progress when most needed","volume":"21","author":"Poggio","year":"2021","journal-title":"Am J Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14320","article-title":"Incidence, risk factors, treatment, and consequences of antibody-mediated kidney transplant rejection: a systematic review","volume":"35","author":"Hart","year":"2021","journal-title":"Clin Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.34067\/kid.0000332022","article-title":"Percutaneous ultrasound-guided kidney transplant biopsy outcomes: from the nephrologist to the radiologist standpoint","volume":"3","author":"Mattiazzi","year":"2022","journal-title":"Kidney360"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.04.054","article-title":"Relevance of the Banff human organ transplant consensus gene panel for detecting antibody and T-cell-mediated rejection of kidney allografts","volume":"9","author":"Giarraputo","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13341","article-title":"Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-center pilot study","volume":"32","author":"Shen","year":"2019","journal-title":"Transpl Int"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2015.08.035","article-title":"Donor-derived cell-free DNA is a novel universal biomarker for allograft rejection in solid organ transplantation","volume":"47","author":"Beck","year":"2015","journal-title":"Transplant Proc"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15142","article-title":"Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction","volume":"19","author":"Whitlam","year":"2019","journal-title":"Am J Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1681\/ASN.2021091191","article-title":"The Trifecta study: comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies","volume":"33","author":"Halloran","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03087-3","article-title":"Cell-free DNA for the detection of kidney allograft rejection","volume":"30","author":"Aubert","year":"2024","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study","volume":"101","author":"Bu","year":"2022","journal-title":"Kidney Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000821","article-title":"Donor-derived cell-free DNA identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients","volume":"4","author":"Jordan","year":"2018","journal-title":"Transplant Direct"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004324","article-title":"Antibody-mediated rejection without detectable donor-specific antibody releases donor-derived cell-free DNA: results from the Trifecta study","volume":"107","author":"Halloran","year":"2023","journal-title":"Transplantation"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae282","article-title":"Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial","volume":"40","author":"Akifova","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15289","article-title":"Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients","volume":"19","author":"Huang","year":"2019","journal-title":"Am J Transplant"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.13919","article-title":"Evaluation of a decentralized donor-derived cell-free DNA assay for kidney allograft rejection monitoring","volume":"37","author":"Loupy","year":"2024","journal-title":"Transplant Int"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jcm8010019","article-title":"Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR","volume":"8","author":"Sigdel","year":"2018","journal-title":"J Clin Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05530421","article-title":"Combining blood gene expression and cellfree DNA to diagnose subclinical rejection in kidney transplant recipients","volume":"16","author":"Park","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15822","article-title":"High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury","volume":"20","author":"Stites","year":"2020","journal-title":"Am J Transplant"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2025.07.2470","article-title":"Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: a prospective, multicenter study","volume":"25","author":"Bunnapradist","year":"2025","journal-title":"Am J Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15011","article-title":"Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant","volume":"19","author":"Friedewald","year":"2019","journal-title":"Am J Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.34067\/kid.0000000000000549","article-title":"Clinical value of peripheral blood gene expression profile and donor-derived cellfree DNA for identifying persistent rejection","volume":"5","author":"Heilman","year":"2024","journal-title":"Kidney360"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14987","article-title":"Multiple abnormal peripheral blood gene expression assay results are correlated with subsequent graft loss after kidney transplantation","volume":"37","author":"Heilman","year":"2023","journal-title":"Clin Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.09.021","article-title":"Prospective observational study to validate a next-generation sequencing blood RNA signature to predict early kidney transplant rejection","volume":"24","author":"Bestard","year":"2024","journal-title":"Am J Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018111098","article-title":"A peripheral blood gene expression signature to diagnose subclinical acute rejection","volume":"30","author":"Zhang","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.34067\/KID.0005062021","article-title":"Clinical validation of an immune quiescence gene expression signature in kidney transplantation","volume":"2","author":"Akalin","year":"2021","journal-title":"Kidney360"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2022-0113","article-title":"Validation of a gene expression signature to measure immune quiescence in kidney transplant recipients in the CLIA setting","volume":"16","author":"Cheung","year":"2022","journal-title":"Biomarkers Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001759","article-title":"The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study","volume":"11","author":"Roedder","year":"2014","journal-title":"PloS Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16179","article-title":"Diagnostic performance of kSORT, a blood-based mRNA assay for noninvasive detection of rejection after kidney transplantation: a retrospective multicenter cohort study","volume":"21","author":"Van Loon","year":"2021","journal-title":"Am J Transplant"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03680.x","article-title":"Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection","volume":"11","author":"Jackson","year":"2011","journal-title":"Am J Transplant"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12426","article-title":"Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury","volume":"13","author":"Hricik","year":"2013","journal-title":"Am J Transplant"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2014080797","article-title":"Urinary C-X-C motif chemokine 10 independently improves the noninvasive diagnosis of antibody-mediated kidney allograft rejection","volume":"26","author":"Rabant","year":"2015","journal-title":"J Am Soc Nephrol JASN"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13677","article-title":"Early low urinary CXCL9 and CXCL10 might predict immunological quiescence in clinically and histologically stable kidney recipients","volume":"16","author":"Rabant","year":"2016","journal-title":"Am J Transplant"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.12659\/aot.929491","article-title":"Urinary C-X-C motif chemokine 10 is related to acute graft lesions secondary to T cell- and antibody-mediated damage","volume":"26","author":"Arnau","year":"2021","journal-title":"Ann Transplant"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31822d4de1","article-title":"Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitis","volume":"92","author":"Ho","year":"2011","journal-title":"Transplantation"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1681\/asn.0000000000000160","article-title":"Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10 chemokine","volume":"34","author":"Hirt-Minkowski","year":"2023","journal-title":"J Am Soc Nephrol JASN"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13584","article-title":"Longitudinal assessment of the CXCL10 blood and urine concentration in kidney transplant recipients with BK polyomavirus replication-a retrospective study","volume":"33","author":"Weseslindtner","year":"2020","journal-title":"Transplant Int Off J Eur Soc For Organ Transplant"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15959","article-title":"Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection","volume":"20","author":"Tinel","year":"2020","journal-title":"Am J Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004554","article-title":"Multicenter validation of a urine CXCL10 assay for noninvasive monitoring of renal transplants","volume":"107","author":"Ho","year":"2023","journal-title":"Transplantation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"20357","DOI":"10.1038\/s41598-024-70390-x","article-title":"Transforming kidney transplant monitoring with urine CXCL9 and CXCL10: practical clinical implementation","volume":"14","author":"Tinel","year":"2024","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000742","article-title":"Detection of kidney allograft rejection using urinary chemokines","volume":"36","author":"Goutaudier","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Yanez-Mo","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2014.00057","article-title":"Perturbations in the urinary exosome in transplant rejection","volume":"1","author":"Sigdel","year":"2014","journal-title":"Front Med (Lausanne)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1681\/asn.2020060850","article-title":"Discovery and validation of a urinary exosome mRNA signature for the diagnosis of human kidney transplant rejection","volume":"32","author":"El Fekih","year":"2021","journal-title":"J Am Soc Nephrol JASN"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2025.01.036","article-title":"An exosomal mRNA urine test for detection and risk stratification of human kidney transplant rejection","volume":"10","author":"El Fekih","year":"2025","journal-title":"Kidney Int Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204204","article-title":"Novel urinary exosomal biomarkers of acute T cell-mediated rejection in kidney transplant recipients: a cross-sectional study","volume":"13","author":"Lim","year":"2018","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/biomedicines12010116","article-title":"MicroRNAs as potential graft rejection or tolerance biomarkers and their dilemma in clinical routines behaving like devilish, angelic, or frightening elements","volume":"12","author":"Legaz","year":"2024","journal-title":"Biomedicines"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190576","article-title":"Development and validation of urinary exosomal microRNA biomarkers for the diagnosis of acute rejection in kidney transplant recipients","volume":"14","author":"Seo","year":"2023","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/tp.0000000000000873","article-title":"Identification of T cell-mediated vascular rejection after kidney transplantation by the combined measurement of 5 specific microRNAs in blood","volume":"100","author":"Matz","year":"2016","journal-title":"Transplantation"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2016.09.001","article-title":"Free microRNA levels in plasma distinguish T-cell mediated rejection from stable graft function after kidney transplantation","volume":"39","author":"Matz","year":"2016","journal-title":"Transpl Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trim.2015.05.002","article-title":"Differential expression of microRNAs in renal transplant patients with acute T-cell mediated rejection","volume":"33","author":"Soltaninejad","year":"2015","journal-title":"Transpl Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7744","DOI":"10.3390\/ijms25147744","article-title":"Torque Teno Virus: A promising biomarker in kidney transplant recipients","volume":"25","author":"Dal Lago","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000003619","article-title":"Torque Teno Virus load is associated with subclinical alloreactivity in kidney transplant recipients: A prospective observational trial","volume":"105","author":"Doberer","year":"2021","journal-title":"Transplantation"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15810","article-title":"Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients-a prospective observational trial","volume":"20","author":"Doberer","year":"2020","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surgeons"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz039","article-title":"Torque Teno Virus for risk stratification of acute biopsy-proven alloreactivity in kidney transplant recipients","volume":"219","author":"Strassl","year":"2019","journal-title":"J Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2023.12115","article-title":"Frontiers Publishing Partnerships | European Society of Organ Transplantation consensus statement on testing for non-invasive diagnosis of kidney allograft rejection","volume":"36","author":"Park","year":"2024","journal-title":"Transplant Int"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2024.07.018","article-title":"Biomarkers of rejection in kidney transplantation","volume":"85","author":"Westphal","year":"2025","journal-title":"Am J Kidney Dis Off J Natl Kidney Foundation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/tp.0000000000004624","article-title":"The molecular phenotype of kidney transplants: Insights from the MMDx project","volume":"108","author":"Halloran","year":"2024","journal-title":"Transplantation"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000004372","article-title":"Feasibility and potential of transcriptomic analysis using the NanoString nCounter technology to aid the classification of rejection in kidney transplant biopsies","volume":"107","author":"Varol","year":"2023","journal-title":"Transplantation"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2025.116911","article-title":"A thorough clinical study pipeline to discover and validate biomarkers in kidney transplantation: The European BIOMARGIN program","volume":"263","author":"Marquet","year":"2025","journal-title":"J Pharm BioMed Anal"},{"key":"B61","unstructured":"The European Transplantation and Innovation Consortium For Risk Stratification in Kidney Transplant Patients (EU-TRAIN)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801117\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:26:16Z","timestamp":1782707176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801117\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2026.1801117"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1801117","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1801117"}}